MacroGenics (MGNX) gains as Citi upgrades to Buy
Tweet Send to a Friend
Shares of biopharmaceutical company, MacroGenics, Inc. (NASDAQ: MGNX) surged as much as 15.60% in early trading on Wednesday after Citi ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
